In-depth, public interest health journalism.

Menu
Spotlight
  • News
    • Latest
    • HIV/AIDS
    • TB
    • NHI
    • Healthcare system
    • Access to Medicines
    • Newsletters
  • Provinces
    • Eastern Cape
    • Free State
    • Gauteng
    • KwaZulu-Natal
    • Limpopo
    • Mpumalanga
    • North West
    • Northern Cape
    • Western Cape
  • Special Projects
    • #InTheSpotlight
    • #InsideTheBox
    • #Vote4Health
    • Health4Sale
  • Perspectives
    • Editorial
    • Opinions
  • About Us
Home Blog moxifloxacin

Tag: moxifloxacin

Back To Blog

Shorter, simpler DR-TB regimen expected later this year

Posted in: Edition 10: Drug-resistant TB, Latest, NSP and SANAC, TB, TB

A new six-month treatment regimen for drug-resistant forms of tuberculosis is expected to be rolled out in the public sector later this year – current regimens take anything from nine to 18 months. Catherine Tomlinson unpacks why the switch is important and outlines what still needs to happen to make it a reality.

Read More

Shorter, simpler DR-TB regimen expected later this year

TB treatment time cut by a third

Posted in: Edition 10: Drug-resistant TB, Edition 7: TB, HIV/AIDS, Latest, TB

A new four-month treatment course for drug-sensitive tuberculosis (the most common form of TB by far) is as safe and effective as the current six-month treatment course that has been in use since the 1980s, according to findings from a large new study. Amy Green reports.

Read More

TB treatment time cut by a third

Sign up to get stories that matter in your inbox

Spotlight

An online publication monitoring South Africa's response to TB and HIV, the state of our health systems, and the people that use it and keep it going. You can contact us at Editors@SpotlightNSP.co.za. Find out more about us here.

Spotlight

Spotlight is a member of the South African Press Council and is subject to the South African Press Code. You can read the press code here and find details about how to complain to the press council here should you take issue with any of our stories.

© 2025 Spotlight All Rights Reserved

  • Twitter
  • Facebook
  • BSKY